Amarin Corp Plcuk (AMRN) Other Operating Expenses (2022 - 2026)
Amarin Corp Plcuk (AMRN) reported Other Operating Expenses of $3.1 million for Q1 2026, down 89.92% year-over-year from $31.2 million in Q1 2025, and up 105.01% quarter-over-quarter from -$62.8 million in Q4 2025.
Amarin Corp Plcuk (AMRN) Other Operating Expenses (2022 - 2026) Analysis & Trends
Amarin Corp Plcuk (AMRN) has 5 years of Other Operating Expenses data on file, last reported at $3.1 million in Q1 2026.
- Other Operating Expenses for Q1 2026 came in at $3.1 million, down 89.92% year-over-year; the trailing twelve-month figure through Mar 2026 was -$46.0 million (down 326.74% YoY), and the FY2024 annual result was $12.6 million, down 2.75% from the prior year.
- Other Operating Expenses advanced to $3.1 million in Q1 2026 per AMRN's latest filing, from -$62.8 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $31.2 million in Q1 2025 and troughed at -$74.2 million in Q4 2024.
- A 5-year average of -$3.1 million and a median of $7.9 million in 2022 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2024 and 2025: Other Operating Expenses sank 673.4% in 2024, then soared 336.73% in 2025.
- A 5-year view of Other Operating Expenses shows it stood at $12.6 million in 2022, then grew by 2.4% to $12.9 million in 2023, then slumped by 673.4% to -$74.2 million in 2024, then climbed by 15.47% to -$62.8 million in 2025, then surged by 105.01% to $3.1 million in 2026.
- Business Quant data shows AMRN's Other Operating Expenses at $3.1 million in Q1 2026, -$62.8 million in Q4 2025, and $13.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn |
| 10 | Amarin Corp Plcuk | 5.84 Bn | 5.66 Bn | 17.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.14 Mn |
| Dec 31, 2025 | -62.76 Mn |
| Sep 30, 2025 | 13.60 Mn |
| Mar 31, 2025 | 31.20 Mn |
| Dec 31, 2024 | -74.25 Mn |
| Sep 30, 2024 | 3.12 Mn |
| Jun 30, 2024 | 29.16 Mn |
| Dec 31, 2023 | 12.95 Mn |
| Dec 31, 2022 | 12.65 Mn |
| Jun 30, 2022 | 13,000.00 |